Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-first-once-weekly-insulin-type-2-diabetes-2026a10009mv?src=rss
Author :
Publish date : 2026-03-30 13:23:00
Copyright for syndicated content belongs to the linked Source.
